Predicate Devices

Not Found

Reference Devices

Not Found

AI/ML (Artificial Intelligence / Machine Learning)

No
The document describes a standard ultrasound imaging system with image display, storage, and basic analysis functions. There is no mention of AI, ML, or advanced image processing that would suggest the use of these technologies.

Therapeutic

No
The device is described as an imaging and diagnostic tool for various medical conditions, not a device used to provide therapy or treatment.

Diagnostic

Yes

The "Intended Use / Indications for Use" section explicitly states "plastic/reconstructive surgery planning and assessment, dematological assessment and diagnosis," and "medical/surgical dermatology assessment and diagnosis (aesthetic and therapeutic), plastic/reconstructive surgical planning, wound assessment and management, skin assessment for pressure ulcer detection and prevention, and superficial musculoskeletal diagnosis." The "Device Description" also mentions "Operation of the Episcan I-200 is similar to that of most medical diagnostic ultrasound systems in clinical use today." These phrases clearly indicate that the device is used for diagnostic purposes.

SaMD (Software as a Medical Device)

No

The device description explicitly states it consists of two main components: a hand-held ultrasound probe and a portable instrument/computer body with a monitor and keyboard, indicating it includes hardware components beyond just software.

IVD (In Vitro Diagnostic)

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

IVD Definition: In Vitro Diagnostic devices are used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information about a person's health.
Device Function: The Episcan I-200 is an ultrasound system that uses sound waves to create images of the skin and underlying soft tissue directly on the patient's body. It does not analyze samples taken from the body.
Intended Use: The intended use clearly describes imaging and assessment of anatomical sites on the patient, not the analysis of biological specimens.

Therefore, the Episcan I-200 falls under the category of medical imaging devices, not In Vitro Diagnostic devices.

PCCP (Predetermined Change Control Plan) Authorized

N/A

Overview

Intended Use / Indications for Use

"High resolution ultrasound imaging for wounds, superficial musculoskeletal diagnosis and assessment, plastic/reconstructive surgery planning and assessment, dematological assessment and diagnosis, and aesthetic application"

The EPISCAN I-200 high resolution ultrasound system is a specialized system for imaging the skin and underlying soft tissue. It is intended for use by clinicians, or under the direction of physicians for imaging and analysis in research environments as well as clinical settings including medical/surgical dermatology assessment and diagnosis (aesthetic and therapeutic), plastic/reconstructive surgical planning, wound assessment and management, skin assessment for pressure ulcer detection and prevention, and superficial musculoskeletal diagnosis.

Product codes (comma separated list FDA assigned to the subject device)

IYO, ITX

Device Description

The Episcan I-200 has been developed to examine the human skin and the first few centimeters of underlying soft tissue using ultrasound of center frequency 20 MHz. The system displays the information obtained in the form of brightness or B-scans, which are presented either color-coded or grayscale images. These images can be stored on magnetic media, printed or transferred electronically for archive or analysis. Physically, the system consists of two main components: the hand-held ultrasound probe and the portable instrument/computer body with its monitor and keyboard. Operation of the Episcan I-200 is similar to that of most medical diagnostic ultrasound systems in clinical use today. The near real-time imaging of the scanner allows you to view the scanner's screen as you reposition the probe and alter the scanner's parameters. The image can be saved to a disk, printed, forwarded via a network or modem to a remote location or discarded. The Episcan I-200 contains enhancements or new features including short cut menus; adjust and move measurements and annotations; copy and paste measurements and annotations, tidy and repair databases, and new analysis functions.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Ultrasound

Anatomical Site

human skin and the first few centimeters of underlying soft tissue

Indicated Patient Age Range

Not Found

Intended User / Care Setting

clinicians, or under the direction of physicians for imaging and analysis in research environments as well as clinical settings

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

Not Found

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

Regulation Number and Section

§ 892.1560 Ultrasonic pulsed echo imaging system.

(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

Summary

0

K06251

PREMARKET NOTIFICATION 510(k) SUMMARY

| 1. Submitted by: | Michael G. Farrow, Ph.D., Consultant
4239 32nd Road, South
Arlington, VA 22206
Telephone: (202) 285-2626
E-mail: farrow002@yahoo.com |

------------------	--------------------------------------------------------------------------------------------------------------------------------------------------

NUV 2 1 2006

1. Contact Person: Michael G. Farrow, Ph.D. (Official Correspondent)

3. Name of the Device:

Longport™ Episcan 1-200 a. Trade Name: b. Common Name: Ultrasound Scanner c. Classification Name: Class II 90 IYO
System, Imaging, Pulsed Echo, Ultrasonic

4. Legally Marketed Device(s) for which we are claiming substantial equivalence:

Longport LDS-1 Longport Inc. Spring Valley Business Park 2 Braxton Way, Suite 111 Glen Mills, PA 19342

Hudson 2020, 2040, 2060 Ultrasound Scanner Hudson Diagnostic Imaging, LLC 610 Boulevard Elmwood, NJ

Diasus, Diagnostic Ultrasound System P75LHF, 5-12MHz Ultra wideband Linear Array Probe Dynamic Imaging Limeted 9 Cochrane Square, Brucefield Industrial Part Livingston EH 54 9DR, Scotland, UK

Corte> DermaScan C Ultrasonic Transducer Cortex DermaScan C Ultrasonic System Textilvaeget 1 9560 Hadsund, Denmark

1

5. Description of the Device:

The Episcan I-200 has been developed to examine the human skin and the first few centimeters of underlying soft tissue using ultrasound of center frequency 20 MHz. The system displays the information obtained in the form of brightness or B-scans, which are presented either color-coded or grayscale images. These images can be stored on magnetic media, printed or transferred electronically for archive or analysis. Physically, the system consists of two main components: the hand-held ultrasound probe and the portable instrument/computer body with its monitor and keyboard. Operation of the Episcan I-200 is similar to that of most medical diagnostic ultrasound systems in clinical use today. The near real-time imaging of the scanner allows you to view the scanner's screen as you reposition the probe and alter the scanner's parameters. The image can be saved to a disk, printed, forwarded via a network or modem to a remote location or discarded. The Episcan I-200 contains enhancements or new features including short cut menus; adjust and move measurements and annotations; copy and paste measurements and annotations, tidy and repair databases, and new analysis functions.

6. Intended Use of the Device: Current indication for use:

"High resolution ultrasound imaging for wounds, superficial musculoskeletal diagnosis and assessment, plastic/reconstructive surgery planning and assessment, dematological assessment and diagnosis, and aesthetic application"

7. Summary of Technological Characteristics compared to Predicate Device:

Technological characteristics of this device which are similar to those of the predicates are:

1. Transducer Center Frequency
1. Scanning Mode
1. Scan Field/Length
1. Transducer stand-off medium
1. Water Reservoir retention
1. Windows Operating System
1. Operator Control
1. Data Format
1. Data Storage
1. Distance Measurement
1. Split Screen Features

2

Palattes 13) Safety
Power Requirement
Power Consumption
Operating Temperature and Humidity

Technological characteristics of this device which are different than those of the predicates are:

Transducer type
Scan rate

3

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three stripes forming its body and wings. The eagle is oriented diagonally, facing upwards and to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Longport, Inc. % Michael Farrow, Ph.D. Consultant 4239 32" Road, South ARLINGTON VA 22206

NOV 2 1 2006

Re: K062571

Trade Name: Longport Model Episcan I-200, Ultrasound System Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulation Number: 21 CFR 892.1570 Regulation Name: diagnostic ultrasonic transducer Regulatory Class: II Product Code: IYO and ITX Dated: November 13, 2006 Received: November 13, 2006

Dear Dr. Farrow:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

This determination of substantial equivalence applies to the following transducers intended for use with the Longport Model Episcan I-200, Ultrasound System as described in your premarket notification:

Transducer Model Number

1030-20, 20 MHz (10-30MHz) 0931-12, 20MHz (9-31MHz)

Image /page/3/Picture/13 description: The image is a circular logo with the letters "FDA" in large, bold font in the center. Above the letters, the years "1906 - 2006" are printed. Below the letters, the word "Centennial" is printed in a cursive font, followed by three stars. The logo is surrounded by a circular border with text that is difficult to read due to the image quality.

Protecting and Promoting Public Health

4

0931-10, 20MHz (9-31MHz)
0931-07, 20 MHz (9-31MHz)
1248-07 30 MHz (12-48MHz)
1248-10, 30 MHz (12-48MHz)
1248-12, 30 MHz (12-48MHz)

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This determination of substantial equivalence is granted on the condition that prior to shipping the first device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested in Appendix G, (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." If the special report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply to the production units which as a result may be considered adulterated or misbranded.

The special report should reference the manufacturer's 510(k) number. It should be clearly and prominently marked "ADD-TO-FILE" and should be submitted in duplicate to:

Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850

This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled,

5

Page 3 - Dr. Farrow

"Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html

If you have any questions regarding the content of this letter, please contact Andrew Kang at (240) 276-3666.

Sincerely yours,

Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure(s)

6

Indications for Use

The EPISCAN I-200 high resolution ultrasound system is a specialized system for imaging the skin and underlying soft tissue. It is intended for use by clinicians, or under the direction of physicians for imaging and analysis in research environments as well as clinical settings including medical/surgical dermatology assessment and diagnosis (aesthetic and therapeutic), plastic/reconstructive surgical planning, wound assessment and management, skin assessment for pressure ulcer detection and prevention, and superficial musculoskeletal diagnosis.

6

Nancy C. Hogdon
(Division Sign-Off)

Division of Reproductive, Abdominal, and Radiological Devices R06257 510(k) Number ________________________________________________________________________________________________________________________________________________________________

7

K 062571

Transducer Model Number 1030-20 High Resolution Probe 20mm focus transducer Scan Length 15mm Nominal frequency 20 MHz (10-30MHz)

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human hody as follows;

| Clinical Application | A | B | M | PWD | CWD | COLOR
DOPPLER | Amplitude
Doppler | Color
Velocity
Imaging | Combined
(Specify) | Other
(Specify) |
|----------------------------------|---|---|---|-----|-----|------------------|----------------------|------------------------------|-----------------------|--------------------|
| Ophthalmic | | | | | | | | | | |
| Abdominal | | | | | | | | | | |
| Intraoperative
(specify) | | | | | | | | | | |
| Intraoperative
Neurological | | | | | | | | | | |
| Pediatric | | | | | | | | | | |
| Small Organ
(specify) | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | |
| Cardiac | | | | | | | | | | |
| Transesophageal | | | | | | | | | | |
| Transrectal | | | | | | | | | | |
| Transvaginal | | | | | | | | | | |
| Transurethral | | | | | | | | | | |
| Intervascular | | | | | | | | | | |
| Peripheral Vascular | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | |
| Musculo-skeletal
Conventional | | | | | | | | | | |
| Musculo-skeletal
Superficial | N | N | | | | | | | | |
| Other (Specify) | P | | | | | | | | | |

N=New Indication: P=previously cleared by FDA; E=addcd under Appellclix E

Additional Comments: P= skin and underlying soft tissue.

Qther No mound management, and assessment, detection and pressure ulcers, detection of

deen tissue injury, burn depth assessment differentints edema from Lymphedema

(Grevel: DO ADLE ARKAR BEFOW IIHR THAF-COMITANT OD ADDITIEN TIME DEDICO)

7

Concurrence of CDRII, Office of Device Evaluation (ODB)

Prescription Use (Per 21 CFR 801 . 109)

Nancy Morgan
(Division Sign-Off)
Division of Reproductive, Abdominal,

and Radiological Devices

510(k) Number _

8

K062571

Transducer Model Number 0931-12 High Resolution Probe 12mm focus transduccr Scan Length 15mm Nominal frequency 20 MHz (9-31 MHz)

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application	Mode of Operation
	A	B	M	PWD	CWD	COLOR
DOPPLER	Amplitude
Doppler	Color
Velocity
Imaging	Combined
(Specify)	Other
(Specify)
Ophthalmic
Fetal
Abdominal
Intraoperative
(specify)
Intraoperative
Neurological
Pediatric
Small Organ
(specify)
Adult Cephalic
Neonatal Cephalic
Cardiac
Transesophageal
Transrectal
Transvaginal
Transurethral
Intervascular
Peripheral Vascular
Laparoscopic
Musculo-skeletal
Conventional
Musculo-skeletal
Superficial	N	N
Other (Specify)	N	N

dication; P-previously cicared by FDA: E=added under Appendix E

Assessment, clinical dermately management, and assessment, and assessment, and any and excludes to a

assessment, clinical dermatology, skin lesion assessment, acathetics

THE WE CONSEMBER OF CONTINES FINE-CONTINATE ON ANOTHER FACTORIAL AND FREATED

Concurrence of CDRH, Office of Device Evaluation (ODE)

Proscription Use (Per 21 CFR 801.109)

Nancy C. Bergdon
(Division Sign-Off)

Division of Reproductive, Ab and Radiological Devices 510(k) Number ________________________________________________________________________________________________________________________________________________________________

8

9

K062571

Transducer Model Number 0931-10 High Resolution Probe 10mm focus transducer Scan Length 15mm Nominal frequency 20 MHz (9-31 MHz)

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

| Clinical Application | A | B | M | PWD | CWD | COLOR
DOPPLER | Amplitude
Doppler | Color
Velocity
Imaging | Combined
(Specify) | Other
(Specify) |
|----------------------------------|---|---|---|-----|-----|------------------|----------------------|------------------------------|-----------------------|--------------------|
| Ophthalmic | | | | | | | | | | |
| Fetal | | | | | | | | | | |
| Abdominal | | | | | | | | | | |
| Intraoperative
(specify) | | | | | | | | | | |
| Intraoperative
Neurological | | | | | | | | | | |
| Pediatric | | | | | | | | | | |
| Small Organ
(specify) | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | |
| Cardiac | | | | | | | | | | |
| Transesophageal | | | | | | | | | | |
| Transrectal | | | | | | | | | | |
| Transvaginal | | | | | | | | | | |
| Transurethral | | | | | | | | | | |
| Intervascular | | | | | | | | | | |
| Peripheral Vascular | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | |
| Musculo-skeletal
Conventional | | | | | | | | | | |
| Musculo-skeletal
Superficial | | | | | | | | | | |
| Other (Specify) | N | N | | | | | | | | |
| Mode of Operation | | | | | | | | | | |

N=New Indication; P=previously cleared by FDA; E=added under Appendix E

Additional Comments: Other N= wound management and assessment superficial musculoskeletal

assessment. clinical dermatology, seatherics

Circuse do not meme berow. This that that continue on violher sode it vietided

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nancy C. Braga
(Division Sign-Off)

9 Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number __

10

K062571

Appendix F

Transducer Model Number 0931-07 Migh Resolution Prohe 12mm focus transducer Scan Length 15mm Nominal frequency 20 MHz (9-31 MHz)

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

		Mode of Operation
Clinical Application	A	B	M	PWD	CWD	COLOR
DOPPLER	Amplitude
Doppler	Color
Velocity
Imaging	Combined
(Specify)	Other
(Specify)
Ophthalmic
Fetal
Abdominal
Intraoperative
(specify)
Intraoperative
Neurological
Pediatric
Small Organ
(specify)
Adult Cephalic
Neonatal Cephalic
Cardiac
Transesophageal
Transrectal
Transvaginal
Transurethral
Intervascular
Peripheral Vascular
Laparoscopic
Musculo-skeletal
Conventional
Musculo-skeletal
Superficial
Other (Specify)	N	N

Indication: P-previously cleared by FDA: E-added under Appendly E

Additional Comments: Qther News a

ตรารังลัย อิต คุณา พิหามพิธีทุกพ. โคเพ เจ้าพิพิธ อัตราคารเล่นวันเทพ อังค์เป็นพระอิตภาพ Concurrence of CDRII. Office of Device Evaluation (ODE)

Prescription Usc (Pcr 21 CFR 80)، 109 801، 801، 801، 801، 80

10

Nancy C. Snoddon
(Division Sign-Off)

(Division Sign-Off) Division of Reproductive, Abdo and Radiological Devices 510(k) Number ________________________________________________________________________________________________________________________________________________________________

11

K062571

Transducer Model # 1248-07 Very High Resolution Probe 7.25mm focus transducer Scan Length = 15mm Nominal Frequency = 30 MHz (12 - 48 MHz)

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical Application	Mode of Operation
	A	B	M	PWD	CWD	COLOR
DOPPLER	Amplitude
Doppler	Color
Velocity
Imaging	Combined
(Specify)	Other
(Specify)
Ophthalmic
Fetal
Abdominal
Intraoperative
(specify)
Intraoperative
Neurological
Pediatric
Small Organ
(specify)
Adult Cephalic
Neonatal Cephalic
Cardiac
Transesophageal
Transrectal
Transvaginal
Transurethral
Intervascular
Peripheral Vascular
Laparoscopic
Musculo-skeletal
Conventional
Musculo-skeletal
Superficial
Other (Specify)	N	N

N=New Indication; P=previously cloared by FDA; E=added under Appendix E

Additional Comments:

QTHER = Clinical Dermatology

Aesthetics

SEE ATTACHED DETAILS FOR INDICATIONS FOR USE

Concurrence of CDRH, Office of Device Evaluation (OPE)

Prescription Use (Per 21 CFR 801.109)

Evaluation (ODE)

(Division Sign-Off)
Nancy/Broydon

Appendix F

11

Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number ________________________________________________________________________________________________________________________________________________________________

12

K062571

Transducer Model # 1248-10 Very High Resolution Probe 10mm focus transducer Scan Length = 15mm Nominal Frequency = 30 MHz (12 - 48 MHz)

	Mode of Operation
Clinical Application	A	B	M	PWD	CWD	COLOR
DOPPLER	Amplitude
Doppler	Color
Velocity
Imaging	Combined
(Specify)	Other
(Specify)
Ophthalmic
Fetal
Abdominal
Intraoperative
(specify)
Intraoperative
Neurological
Pediatric
Small Organ
(specify)
Adult Cephalic
Neonatal Cephalic
Cardiac
Transesophageal
Transrectal
Transvaginal
Transurethral
Intervascular
Peripheral Vascular
Laparoscopio
Musculo-skeletal
Conventional
Musculo-skeletal
Superficial
Other (Specify)	N	N

Intended Use: Diagnostic ultrasound imaging or fluid flow aualysis of the human body as follows:

N=New Indication; P=previously cleared by FDA; E=added under Appendix E

Additional Commonts:

QTHER = Cilnical Dermatology

Aesthetics

SEE ATTACHED DETAILS FOR INDICATIONS FOR USE

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Usc (Pet 21 CFR 801.109)

Nancy C. Brogdon

(Division Sign-Off) Division of Reproductive, A and Radiological Devices 510(k) Number _

12

13

K062571

Transducer Model # 1248-12 Very High Resolution Probe 12mm focus transducer Scan Length = 15mm Nominal Frequency = 30 MHz (12 - 48 MHz)

	Mode of Operation
Clinical Application	A	B	M	PWD	CWD	COLOR
DOPPLER	Amplitude
Doppler	Color
Velocity
Imaging	Combined
(Specify)	Other
(Specify)
Ophthalmic
Fetal
Abdominal
Intraoperative
(specify)
Intraoperative
Neurological
Pediatric
Small Organ
(specify)
Adult Cephalic
Neonatal Cephalic
Cardiac
Transesophageal
Transrectal
Transvaginal
Transurethral
Intervascular
Peripheral Vascular
Laparoscopic
Musculo-skeletal
Conventional
Musculo-skeletal
Superficial
Other (Specify)	N	N

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

N=New Indication; Pepreviously cleared by FDA; E=added under Appendix E

Additional Comments:

OTHER = Clinical Dermatology

Acathofics

SEE ATTACHED DETAILS FOR INDICATIONS FOR USE

Conourrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nancy K. Broadon

13

IDivision Sint Off Division of Reproductive, Abde and Radiological Devices 510(k) Number ________________________________________________________________________________________________________________________________________________________________